A group of scientists at the University of California, USA, identified the mechanism by which cancer cells absorb glucose and draw energy for survival and tumor growth.
At the same time, the content of a specific molecule makes it possible to detect a prescientious condition that has to grow, the Medical Express online publication writes.
Experts have found that protein used in the treatment of type 2 diabetes mellitus plays an important role in the formation of new tumor formats. According to the data, the sodium glucose Co-Transporter 2 (SGLT2), which is responsible for glucose transfusion, is one of the major suppliers of "food" for cancer cells.
Cancer cells need glucose to survive and grow. Therefore, they need a lot of transport proteins, glucose transporters.
Previous studies have shown that Sglt2 can play a major role in the development of several types of cancer, including pancreatic and prostate cancer.
Using Pomrome Emission Tomography, researchers have determined the activity of various glucose transporters in cancer cells in different stages of their development. So they found that the cells contained a large amount of sclt 2. According to scientists, this suggests that newly emerging tumors provide carbohydrates mainly by SGLT2 and not by glucose transporters.
By reviewing their data, the researchers also found that SGLT2 increase can occur before a tumor develops, making the specific protein a marker for early detection of the disease.
The discovery of American scientists may have an impact on early cancer prevention methods.